WBA icon

Walgreens Boots Alliance

11.37 USD
-1.15
9.19%
At close Jan 21, 4:00 PM EST
Pre-market
11.32
-0.05
0.44%
1 day
-9.19%
5 days
-4.69%
1 month
22.26%
3 months
8.80%
6 months
0.62%
Year to date
23.72%
1 year
-49.60%
5 years
-78.89%
10 years
-84.96%
 

About: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Employees: 312,000

0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding in top 10

Funds holding in top 10: 4 [Q2] → 4 (+0) [Q3]

2.6% less ownership

Funds ownership: 62.05% [Q2] → 59.45% (-2.6%) [Q3]

6% less funds holding

Funds holding: 917 [Q2] → 862 (-55) [Q3]

11% less call options, than puts

Call options by funds: $246M | Put options by funds: $274M

18% less repeat investments, than reductions

Existing positions increased: 276 | Existing positions reduced: 338

25% less first-time investments, than exits

New positions opened: 114 | Existing positions closed: 153

29% less capital invested

Capital invested by funds: $6.48B [Q2] → $4.62B (-$1.86B) [Q3]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$8.50
25%
downside
Avg. target
$11.42
0%
upside
High target
$14
23%
upside

6 analyst ratings

positive
17%
neutral
67%
negative
17%
Truist Securities
David Macdonald
57% 1-year accuracy
55 / 96 met price target
14%upside
$13
Hold
Maintained
16 Jan 2025
RBC Capital
Ben Hendrix
30% 1-year accuracy
21 / 70 met price target
6%upside
$12
Sector Perform
Maintained
15 Jan 2025
Evercore ISI Group
Elizabeth Anderson
39% 1-year accuracy
13 / 33 met price target
6%upside
$12
In-Line
Maintained
13 Jan 2025
B of A Securities
Allen Lutz
69% 1-year accuracy
9 / 13 met price target
25%downside
$8.50
Underperform
Maintained
13 Jan 2025
Jefferies
Brian Tanquilut
50% 1-year accuracy
7 / 14 met price target
21%downside
$9
Hold
Maintained
23 Oct 2024

Financial journalist opinion

Based on 85 articles about WBA published over the past 30 days

Positive
Investopedia
9 hours ago
Walgreens Stock Stumbles Amid Legal Challenges, Throwing Cold Water on Hopes for a Rebound
After a tough year for Walgreens (WBA) investors in 2024, shares may have appeared poised to start 2025 on strong note after the company's first-quarter results topped expectations.
Walgreens Stock Stumbles Amid Legal Challenges, Throwing Cold Water on Hopes for a Rebound
Neutral
PRNewsWire
10 hours ago
WBA Investor News: Rosen Law Firm Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation - WBA
NEW YORK , Jan. 21, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) resulting from allegations that Walgreens may have issued materially misleading business information to the investing public. So What: If you purchased Walgreens securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WBA Investor News: Rosen Law Firm Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation - WBA
Negative
Investopedia
12 hours ago
S&P 500 Gains and Losses Today: Walgreens Stock Plummets as DOJ Files Lawsuit
Major U.S. equities indexes advanced as the markets kicked off a shortened trading week following the Martin Luther King Jr. holiday and President Donald Trump's inauguration.
S&P 500 Gains and Losses Today: Walgreens Stock Plummets as DOJ Files Lawsuit
Negative
Investopedia
17 hours ago
Walgreens Stock Tumbles on DOJ Lawsuit Over 'Millions' of Alleged Illegal Prescriptions
Walgreens Boots Alliance (WBA) shares sank Tuesday, the first day of trading since the Department of Justice (DOJ) on Friday announced a lawsuit accusing the pharmacy chain of dispensing "millions of unlawful prescriptions" that had no legitimate medical purpose.
Walgreens Stock Tumbles on DOJ Lawsuit Over 'Millions' of Alleged Illegal Prescriptions
Negative
The Motley Fool
18 hours ago
Why Walgreens Boots Alliance Stock Was Sliding Today
Shares of Walgreens Boots Alliance (WBA -12.50%) pulled back today after the company again ran into trouble with regulators.
Why Walgreens Boots Alliance Stock Was Sliding Today
Negative
Benzinga
18 hours ago
Justice Department Accuses Walgreens Of Violating Drug Laws In Opioid Epidemic, Ignored Red Flags In Opioid Crisis
Last week, the U.S. Department of Justice filed a civil complaint against Walgreens Boots Alliance Inc WBA and its subsidiaries, alleging widespread violations of the Controlled Substances Act (CSA) and False Claims Act (FCA).
Justice Department Accuses Walgreens Of Violating Drug Laws In Opioid Epidemic, Ignored Red Flags In Opioid Crisis
Negative
Investors Business Daily
19 hours ago
Walgreens Reverses 40% Sprint As DOJ Slams Opioid Prescriptions
Walgreens stock tumbled Tuesday after the DOJ said the retail pharmacy violated federal law by filling controlled substance prescriptions. The post Walgreens Reverses 40% Sprint As DOJ Slams Opioid Prescriptions appeared first on Investor's Business Daily.
Walgreens Reverses 40% Sprint As DOJ Slams Opioid Prescriptions
Neutral
Accesswire
20 hours ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Walgreens Boots Alliance, Inc. (WBA) and Encourages Stockholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA). Investors who purchased Walgreens securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WBA.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Walgreens Boots Alliance, Inc. (WBA) and Encourages Stockholders to Learn More About the Investigation
Negative
Benzinga
22 hours ago
New Oriental Education, Walgreens And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Tuesday.
New Oriental Education, Walgreens And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Positive
The Motley Fool
1 day ago
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
The S&P 500 (^GSPC 1.00%) has been on fire for the last two years, racking up a gain of nearly 51%, which it hadn't done since the dot-com era. Along the way, however, its valuation has gotten stretched, which means its dividend yield has fallen, with the exchange-traded funds that track the index now paying a yield of just 1.2%.
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
Charts implemented using Lightweight Charts™